Brief: Aspira Women's Health Appoints Marlene Mclennan As Company's Interim CFO
30/11/2022 22:11
Nov 30 (Reuters) - Aspira Women's Health Inc AWH.O :
* ON NOV 28, 2022, BOARD APPOINTED MARLENE MCLENNAN AS
COMPANY’S
INTERIM CFO EFFECTIVE AS OF DECEMBER 1, 2022
Further company coverage: AWH.O
((Reuters.Briefs@thomsonreuters.com))
Recent news on Aspira Women's Health
See all newsBrief: Aspira Women’S Health Announces Receipt Of Delisting Notification From Nasdaq
Brief: Aspira Women's Health On April 4, Enters Equity Purchase Agreement With Triton Funds
Brief: Aspira Women's Health Files For Offering Up To 50 Units, 50 Mln Pre-Funded Units
Brief: Aspira Women's Health Interim CFO John Kallassy Resigns
Brief: Aspira Women's Health Fails To Regain Nasdaq Compliance